The polyglutamine-expanded androgen receptor has increased DNA binding and reduced transcriptional activity

• Published in: Biochemistry and biophysics reports Vol. 3; pp. 134 - 139
• Main Authors: Belikov, Sergey, Bott, Laura C, Fischbeck, Kenneth H, Wrange, Örjan
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier 01.09.2015
• Subjects: bp, basepair; Expanded polyglutamine repeat; SBMA, spinal and bulbar muscular atrophy; Chromatin; Transcription; polyQ, polyglutamine; DMS, dimethylsulphate; WB, Western blotting; DNA binding; MMTV, mouse mammary tumor virus; NTD, N-terminal domain; Androgen receptor; ARE(s), androgen response element(s); AR, androgen receptor; Xenopus oocyte
• ISSN: 2405-5808; 2405-5808
• DOI: 10.1016/j.bbrep.2015.07.014

Expansion of a polyglutamine-encoding trinucleotide CAG repeat in the androgen receptor (AR) to more than 37 repeats is responsible for the X-linked neuromuscular disease spinal and bulbar muscular atrophy (SBMA). Here we evaluated the effect of polyglutamine length on AR function in oocytes. This allowed us to correlate the nuclear AR concentration to its capacity for specific DNA binding and transcription activation . AR variants with polyglutamine tracts containing either 25 or 64 residues were expressed in oocytes by cytoplasmic injection of the corresponding mRNAs. The intranuclear AR concentration was monitored in isolated nuclei and related to specific DNA binding as well as transcriptional induction from the hormone response element in the mouse mammary tumor virus (MMTV) promoter. The expanded AR with 64 glutamines had increased capacity for specific DNA binding and a reduced capacity for transcriptional induction as related to its DNA binding activity. The possible mechanism behind these polyglutamine-induced alterations in AR function is discussed.